This drug combination is used to treat type 2 diabetes mellitus. This combination helps to control blood sugar levels in individuals with type 2 diabetes.
Use with caution if you have liver disease.
Use with caution if you have kidney disease.
Avoid alcohol consumption as it can increase the risk of hypoglycemia and lactic acidosis.
Avoid driving if you experience dizziness or other side effects.
Consult your doctor before using this medication during pregnancy.
Consult your doctor before using this medication while breastfeeding.
Glimepiride: Stimulates the release of insulin from the pancreas, helping to lower blood sugar levels. Metformin: Decreases glucose production in the liver, reduces the absorption of glucose from the intestines, and improves insulin sensitivity, allowing the body to use insulin more effectively.
Type 2 diabetes mellitus is a condition of high blood sugar level despite the production of sufficient amounts of insulin in your body. This happens because of insulin resistance, which means the cells become resistant to insulin and are not able to use it effectively. It can lead to symptoms like increased thirst, frequent urination, and fatigue.
Yes, the use of Glycomet-GP can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, over-exercise or take other antidiabetic medicine along with it. So, regular monitoring of the blood sugar level is important. Always keep a quick source of sugar like glucose tablets, honey or fruit juice with you.
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
No, it is not safe to take Glycomet-GP along with alcohol, as it may lower your blood sugar levels and lead to hypoglycemia. It can also increase the chances of lactic acidosis.
Yes, the use of Glycomet-GP can cause Vitamin B12 deficiency on long-term use. It interferes with the absorption of Vitamin B12 in the stomach. If untreated, it may cause anemia and nerve problems and the patient can experience tingling sensation and numbness in hands and feet, weakness, urinary problems, change in mental status and difficulty in maintaining balance (ataxia). To avoid such problems, some researchers suggest an intake of Vitamin B12 from outside sources at least once every year.
The use of Glycomet-GP is associated with common side effects like hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, headache and upper respiratory tract infection. Its use can also lead to serious but rare side effects like lactic acidosis. On long-term use it can also lead to Vitamin B12 deficiency.
Yes, the use of Glycomet-GP can lead to lactic acidosis. It is a medical emergency which is caused by increased levels of lactic acid in the blood. It is also known as MALA (Metformin-associated lactic acidosis). It is a rare side effect associated with the use of metformin and therefore, it is considered to be harmful for patients with underlying kidney disease, old age patients or who take large amounts of alcohol. Symptoms of lactic acidosis may include muscle pain or weakness, dizziness, tiredness, feeling of cold in arms and legs, difficulty in breathing, nausea, vomiting, stomach pain or slow heart rate. If you have these symptoms, stop taking Glycomet-GP and consult your doctor immediately.
Glycomet-GP is a combination of two medicines: Glimepiride and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. This combination is not indicated for the treatment of type 1 DM.
B.Pharma + MBA
Content Updated on
Friday, 13 September, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA